SCHEMBL2017485

SCHEMBL2017485

CC(C)[Si](O)(c1cccc(Br)c1)C(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
MAPK1 P28482 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MAOA P21397 1/20 0.37
GAA P10253 1/20 0.37
CA1 P00915 1/20 0.37
MMP2 P08253 1/20 0.37
CA14 Q9ULX7 1/20 0.37
C1S P09871 1/20 0.35
PARP1 P09874 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
GABRA1 P14867 2/20 0.35
GABRG2 P18507 2/20 0.35
GABRB3 P28472 2/20 0.35
GABRA5 P31644 2/20 0.35
GABRA3 P34903 2/20 0.35
NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28477358 0.81 ALDH1A1 (0.43) ALDH1A1MAPK1SMN1; SMN2L3MBTL1MAOA
SCHEMBL8722507 0.79 ALDH1A1 (0.41) ALDH1A1MAPK1SMN1; SMN2L3MBTL1MAOA
SCHEMBL15735445 0.75 ACHE (0.41) SMN1; SMN2PARP1CHRNB2SLC6A2CHRNB4
SCHEMBL2021132 0.75 ESR1 (0.39) ALDH1A1GAAKDM4E
SCHEMBL23457112 0.73 ALDH1A1 (0.48) ALDH1A1MAPK1SMN1; SMN2GAAC1S
SCHEMBL783254 0.73 ALDH1A1 (0.48) ALDH1A1MAPK1SMN1; SMN2GAAC1S
SCHEMBL29945235 0.73 ALDH1A1 (0.48) ALDH1A1MAPK1SMN1; SMN2GAAC1S
SCHEMBL4876931 0.72 ALDH1A1 (0.46) ALDH1A1MAPK1SMN1; SMN2C1SPARP1
SCHEMBL10928549 0.71 ALDH1A1 (0.46) ALDH1A1MAPK1SMN1; SMN2GAAC1S
SCHEMBL21263582 0.71 NPC1 (0.45) ALDH1A1MAPK1SMN1; SMN2L3MBTL1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2341108-B1 Surface treatment method for solid material SHINETSU CHEMICAL CO (JP) 2014-07-02 EP disclosed
US-8541631-B2 Surface treatment method for solid material SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-09-24 US disclosed
EP-2341108-A1 Surface treatment method for solid material Shin-Etsu Chemical Co., Ltd. (JP) 2011-07-06 EP disclosed
US-20110160464-A1 SURFACE TREATMENT METHOD FOR SOLID MATERIAL SHIN-ETSU CHEMICAL CO., LTD. (JP) 2011-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110160464-A1 SURFACE TREATMENT METHOD FOR SOLID MATERIAL H1-2, H1-0, HRH3 ALDH1A1 4154/4885MAPK1 4356/4885SMN1; SMN2 1345/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.